Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value: $184M (100.0% shares, 0.0% debt)

Holdings (70)

BRISTOL MYERS SQUIBB CO 5.6%
Value $10.24M Shares 200,000 Est. Cost Unrealized
VALEANT PHARMACEUTICALS INTL 3.6%
Value $6.56M Shares 50,000 Est. Cost Unrealized
ABBVIE INC 3.1%
Value $5.776M Shares 100,000 Est. Cost Unrealized
AGILENT TECHNOLOGIES INC 3.1%
Value $5.698M Shares 100,000 Est. Cost Unrealized
CYH COMMUNITY HEALTH SYS INC NEW 3.0%
Value $5.479M Shares 100,000 Est. Cost $34.00 Unrealized +22.2%
HORIZON PHARMA PLC 2.8%
Value $5.219M Shares 425,000 Est. Cost $12.28 Unrealized
ZBH ZIMMER HLDGS INC 2.7%
Value $5.028M Shares 50,000 Est. Cost $89.58 Unrealized 0.0%
TORNIER N V 2.6%
Value $4.78M Shares 200,000 Est. Cost $21.17 Unrealized
VRTX VERTEX PHARMACEUTICALS INC 2.4%
Value $4.492M Shares 40,000 Est. Cost $95.21 Unrealized 0.0%
ALLERGAN INC 2.4%
Value $4.455M Shares 25,000 Est. Cost $178.20 Unrealized
CEPHEID 2.4%
Value $4.403M Shares 100,000 Est. Cost Unrealized
HCA HCA HOLDINGS INC 2.3%
Value $4.231M Shares 60,000 Est. Cost $52.14 Unrealized +17.8%
MALLINCKRODT PUB LTD CO 2.2%
Value $4.057M Shares 45,000 Est. Cost $90.16 Unrealized
ZELTIQ AESTHETICS INC 2.1%
Value $3.96M Shares 175,000 Est. Cost $22.63 Unrealized
ISRG INTUITIVE SURGICAL INC 2.1%
Value $3.925M Shares 8,500 Est. Cost $49.65 Unrealized 0.0%
CYBERONICS INC 2.1%
Value $3.837M Shares 75,000 Est. Cost $51.16 Unrealized
ARIAD PHARMACEUTICALS INC 2.1%
Value $3.78M Shares 700,000 Est. Cost $5.40 Unrealized
THORATEC CORP 2.0%
Value $3.742M Shares 140,000 Est. Cost $26.73 Unrealized
ATRC ATRICURE INC 2.0%
Value $3.68M Shares 250,000 Est. Cost $17.88 Unrealized -10.9%
ACCURAY INC 2.0%
Value $3.63M Shares 500,000 Est. Cost $7.26 Unrealized
ACTAVIS PLC 2.0%
Value $3.619M Shares 15,000 Est. Cost $223.07 Unrealized
CONCERT PHARMACEUTICALS INC 1.9%
Value $3.543M Shares 280,966 Est. Cost $12.61 Unrealized
THERAPEUTICSMD INC 1.9%
Value $3.48M Shares 750,000 Est. Cost $5.07 Unrealized
ENVISION HEALTHCARE HLDGS IN 1.9%
Value $3.468M Shares 100,000 Est. Cost $34.68 Unrealized
ZS PHARMA INC 1.8%
Value $3.335M Shares 85,000 Est. Cost $39.24 Unrealized
VALEANT PHARMACEUTICALS INTL 1.8%
Value $3.28M Shares 25,000 Est. Cost $131.20 Unrealized
NEUROCRINE BIOSCIENCES INC 1.7%
Value $3.134M Shares 200,000 Est. Cost Unrealized
CLOVIS ONCOLOGY INC 1.6%
Value $2.948M Shares 65,000 Est. Cost $45.35 Unrealized
PORTOLA PHARMACEUTICALS INC 1.6%
Value $2.907M Shares 115,000 Est. Cost $25.28 Unrealized
GW PHARMACEUTICALS PLC 1.5%
Value $2.83M Shares 35,000 Est. Cost $68.57 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 1.5%
Value $2.734M Shares 35,000 Est. Cost $59.44 Unrealized +8.5%
QUIDEL CORP 1.5%
Value $2.687M Shares 100,000 Est. Cost $26.87 Unrealized
SPECTRANETICS CORP 1.4%
Value $2.657M Shares 100,000 Est. Cost $23.62 Unrealized
BRKR BRUKER CORP 1.4%
Value $2.592M Shares 140,000 Est. Cost $19.52 Unrealized +5.1%
EW EDWARDS LIFESCIENCES CORP 1.4%
Value $2.554M Shares 25,000 Est. Cost $12.39 Unrealized +27.4%
EXAS EXACT SCIENCES CORP 1.3%
Value $2.423M Shares 125,000 Est. Cost $18.34 Unrealized 0.0%
CHIMERIX INC 1.2%
Value $2.223M Shares 80,500 Est. Cost $27.61 Unrealized
PTCT PTC THERAPEUTICS INC 1.2%
Value $2.201M Shares 50,000 Est. Cost $31.28 Unrealized 0.0%
ANTARES PHARMA INC 1.1%
Value $2.013M Shares 1,100,000 Est. Cost $1.83 Unrealized
AEGERION PHARMACEUTICALS INC 1.1%
Value $2.003M Shares 60,000 Est. Cost $33.38 Unrealized
MEDTRONIC INC 1.0%
Value $1.859M Shares 30,000 Est. Cost $63.76 Unrealized
DEPOMED INC 1.0%
Value $1.823M Shares 120,000 Est. Cost $12.77 Unrealized
TANDEM DIABETES CARE INC 1.0%
Value $1.765M Shares 131,500 Est. Cost $13.42 Unrealized
NUVASIVE INC 0.9%
Value $1.744M Shares 50,000 Est. Cost $34.88 Unrealized
AVALANCHE BIOTECHNOLOGIES IN 0.9%
Value $1.71M Shares 50,000 Est. Cost $34.20 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 0.9%
Value $1.567M Shares 100,000 Est. Cost $14.95 Unrealized 0.0%
ACHILLION PHARMACEUTICALS IN 0.8%
Value $1.497M Shares 150,000 Est. Cost Unrealized
ZAFGEN INC 0.8%
Value $1.474M Shares 75,000 Est. Cost $19.65 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 0.8%
Value $1.385M Shares 35,000 Est. Cost $36.87 Unrealized +8.1%
ONCOTHYREON INC 0.7%
Value $1.344M Shares 700,000 Est. Cost $1.92 Unrealized
SNN SMITH & NEPHEW PLC 0.7%
Value $1.263M Shares 15,000 Est. Cost $89.30 Unrealized
BLUEBIRD BIO INC 0.7%
Value $1.256M Shares 35,000 Est. Cost $35.89 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 0.7%
Value $1.227M Shares 20,000 Est. Cost $43.10 Unrealized 0.0%
PBYI PUMA BIOTECHNOLOGY INC 0.6%
Value $1.193M Shares 5,000 Est. Cost $176.01 Unrealized +16.7%
ALIMERA SCIENCES INC 0.6%
Value $1.084M Shares 200,000 Est. Cost Unrealized
VANDA PHARMACEUTICALS INC 0.6%
Value $1.038M Shares 100,000 Est. Cost Unrealized
NANOSTRING TECHNOLOGIES INC 0.5%
Value $985K Shares 90,000 Est. Cost $18.50 Unrealized
ALCOBRA LTD 0.4%
Value $772K Shares 50,000 Est. Cost Unrealized
RECEPTOS INC 0.4%
Value $764K Shares 12,300 Est. Cost $42.60 Unrealized
BIOLASE INC 0.4%
Value $747K Shares 300,000 Est. Cost $2.41 Unrealized
OCERA THERAPEUTICS INC 0.3%
Value $613K Shares 125,000 Est. Cost $10.04 Unrealized
HRTX HERON THERAPEUTICS INC 0.3%
Value $583K Shares 70,000 Est. Cost $11.95 Unrealized -22.0%
LIPOCINE INC NEW 0.3%
Value $561K Shares 91,768 Est. Cost $6.11 Unrealized
ASSEMBLY BIOSCIENCES INC 0.3%
Value $532K Shares 65,000 Est. Cost $8.18 Unrealized
PSIVIDA CORP 0.2%
Value $442K Shares 100,000 Est. Cost $4.42 Unrealized
UNILIFE CORP NEW 0.2%
Value $344K Shares 150,000 Est. Cost $4.21 Unrealized
CATALYST PHARM PARTNERS INC 0.2%
Value $332K Shares 100,000 Est. Cost Unrealized
WRIGHT MED GROUP INC 0.2%
Value $288K Shares 134,000 Est. Cost $1.40 Unrealized
FLEXION THERAPEUTICS INC 0.1%
Value $228K Shares 12,488 Est. Cost $18.26 Unrealized
AMARIN CORP PLC 0.1%
Value $218K Shares 200,000 Est. Cost $1.09 Unrealized